Citations for
1SRI
Beyond the Cardiac Myofilament: Hypertrophic Cardiomyopathy-Associated Mutations in Genes that Encode Calcium-Handling Proteins.
Landstrom AP, Ackerman MJ.
Curr Mol Med urr Mol Med. 2012 Apr 18. [Epub ahead of print] 2012
2MLXIPL, SRI
Roles of Ca2+ ions in the control of ChREBP nuclear translocation.
Leclerc I, Rutter GA, Meur G, Noordeen N.
J Endocrinol 213(2):115-22. Epub 2012 Mar 8. 2012
3MLXIPL, SRI
Glucose-induced nuclear shuttling of ChREBP is mediated by sorcin and Ca(2+) ions in pancreatic β-cells.
Noordeen NA, Meur G, Rutter GA, Leclerc I.
Diabetes 61(3):574-85. Epub 2012 Feb 14. 2012
4SRI
Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis.
Maddalena F, Laudiero G, Piscazzi A, Secondo A, Scorziello A, Lombardi V, Matassa DS, Fersini A, Neri V, Esposito F, Landriscina M.
Cancer Res 71(24):7659-69. Epub 2011 Nov 3. 2011
5SRI
Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp.
He Q, Zhang G, Hou D, Leng A, Xu M, Peng J, Liu T.
Oncol Rep 25(1):237-43. 2011
6ANXA7, SRI, STOM
Echinophilic proteins stomatin, sorcin, and synexin locate outside gangliosideM1 (GM1) patches in the erythrocyte membrane.
Mrówczyńska L, Salzer U, Perutková S, Iglič A, Hägerstrand H.
Biochem Biophys Res Commun 401(3):396-400. Epub 2010 Sep 19. 2010
7SRI, TRAP1
Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents.
Landriscina M, Laudiero G, Maddalena F, Amoroso MR, Piscazzi A, Cozzolino F, Monti M, Garbi C, Fersini A, Pucci P, Esposito F.
Cancer Res 70(16):6577-86. Epub 2010 Jul 20. 2010
8SLC8A1, SRI
Activation of the cardiac Na(+)-Ca(2+) exchanger by sorcin via the interaction of the respective Ca(2+)-binding domains.
Zamparelli C, Macquaide N, Colotti G, Verzili D, Seidler T, Smith GL, Chiancone E.
J Mol Cell Cardiol 49(1):132-41. Epub 2010 Mar 15. 2010
9SRI
Molecular basis for the impaired function of the natural F112L sorcin mutant: X-ray crystal structure, calcium affinity, and interaction with annexin VII and the ryanodine receptor.
Franceschini S, Ilari A, Verzili D, Zamparelli C, Antaramian A, Rueda A, Valdivia HH, Chiancone E, Colotti G.
FASEB J 22(1):295-306. Epub 2007 Aug 15. 2008
10SRI
Expression of a sorcin missense mutation in the heart modulates excitation-contraction coupling.
Collis LP, Meyers MB, Zhang J, Phoon CK, Sobie EA, Coetzee WA, Fishman GI.
FASEB J 21(2):475-87. Epub 2006 Nov 27. 2007
11SRI
Sorcin, an important gene associated with multidrug-resistance in human leukemia cells.
Zhou Y, Xu Y, Tan Y, Qi J, Xiao Y, Yang C, Zhu Z, Xiong D.
Leuk Res 30(4):469-76. Epub 2005 Oct 6. 2006
12SRI
Sorcin regulates excitation-contraction coupling in the heart.
Meyers MB, Fischer A, Sun YJ, Lopes CM, Rohacs T, Nakamura TY, Zhou YY, Lee PC, Altschuld RA, McCune SA, Coetzee WA, Fishman GI.
J Biol Chem 278(31):28865-71. Epub 2003 May 16. 2003
13GCA, PEF1, SRI
The PEF family proteins sorcin and grancalcin interact in vivo and in vitro.
Hansen C, Tarabykina S, la Cour JM, Lollike K, Berchtold MW.
FEBS Lett 545(2-3):151-4. 2003
14ALG2, GCA, PEF1, SRI
Both ALG-2 and peflin, penta-EF-hand (PEF) proteins, are stabilized by dimerization through their fifth EF-hand regions.
Kitaura Y, Satoh H, Takahashi H, Shibata H, Maki M.
Arch Biochem Biophys 399(1):12-8. 2002
15PSEN2, SRI
Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor.
Pack-Chung E, Meyers MB, Pettingell WP, Moir RD, Brownawell AM, Cheng I, Tanzi RE, Kim TW.
J Biol Chem 275(19):14440-5. 2000
16ABCB1, ABCB4, ADAM22, DMTF1, CROT, NADHDL1, SCNEDL, SRI
Localization of 67 exons on a YAC contig spanning 1.5 Mb around the multidrug resistance gene region of human chromosome 7q21.1.
Torigoe K, et al.
Genomics 49 : 14-22. 1998
17SRI
Isolation and molecular cloning of human sorcin a calcium-binding protein in vincristine-resistant HOB1 lymphoma cells.
Wang SL, et al.
Biochim Biophys Acta 1260 : 285-293. 1995
18SRI, SRIL
Genes amplified and overexpressed in human multidrug-resistant cell lines.
Van der Bliek AM, et al.
Cancer Res 48 : 5927-5932. 1988